SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

RxSight Q3 Revenue Falls 19%

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.

RXST
SquawkNews Desk

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original sources.

Related stories

ViriBio shares rise 6% intraday M impact | EQUITY | Nov 04, 2026, 09:06 AM UTC Pagoda shares rise 7% intraday Pagoda shares rose 7% intraday. M impact | EQUITY | Nov 04, 2026, 09:06 AM UTC Lenovo Group Rises More Than 7% Late in Trading M impact | EQUITY | Nov 04, 2026, 09:06 AM UTC Dr. Lal PathLabs Q2 Profit Rises 28%, Revenue Grows 20% Dr. Lal PathLabs reported September-quarter revenue of ₹873.9 crore and declared a ₹5 interim dividend. Shares were trading around 4% higher on Wednesday, November 4. M impact | EQUITY | Nov 04, 2026, 09:06 AM UTC Bin a str​a Unit Accepts Award for Warehouse Facility Worth RGT 303.8 Million M impact | EQUITY | Nov 04, 2026, 09:06 AM UTC Taeyoung E&C Faces Partial Work Halt After Worker Death A worker died at a Taeyoung E&C housing site in Seoul, prompting a partial work halt. M impact | EQUITY | Nov 04, 2026, 09:06 AM UTC